MoneyWorks4Me

Dr Reddys Laboratories informs about quarterly statement of investor complaint

14 Jan 2016 Evaluate

Dr Reddys Laboratories has informed about Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended December 31, 2015, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1743.00
Dr. Reddys Labs. 1303.00
Cipla 1353.00
Lupin 1950.00
Zydus Lifesciences 1158.10
View more..